Santosh Padmagirison is a Finance, Commercial strategy and Analytics executive who has spent nearly two decades helping precision diagnostics, biotechnology, genomics, and technology companies turn data and operational discipline into revenue growth. He currently serves as Vice President, Commercial Operations at Myriad Genetics, where he leads a 30-person team across strategic planning, sales operations, market intelligence, and commercial technology for an $800M molecular diagnostics business spanning oncology, prenatal health, and mental health.

Santosh built his career at the intersection of finance, analytics, and go-to-market execution. As Global Head of Commercial Strategy, Operations, Analytics, and Technology at Ancestry, he helped drive the company's best Q4 in its history, with DNA kit sales up 39% year-over-year. Earlier, at Illumina, he led commercial finance and analytics through a period of growth from $2.5B to $5B in revenue, including standing up an AI-driven sales forecasting system that improved forecast accuracy by 20% and saved millions in operational costs. His foundation in enterprise systems and financial performance management was built over nearly a decade at Qualcomm.

Across every role, Santosh's approach is the same: align commercial, finance, and technology functions around clear data, rigorous forecasting, and scalable processes — then use that foundation to unlock market share and growth. He holds an MS in Management Information Systems from Baylor University (4.0 GPA, Most Outstanding Graduate), an MBA from Ohio University, and a Bachelor's in Finance and Accounting from Osmania University.